Break through the bottleneck! 3D printing + stem cell technology to help nerve regeneration
Release time:
2025-08-29
Spinal cord injury is the "incurable injury" in the global medical community. On August 23, the University of Minnesota team published a major study in "Advanced Medical Materials", which opened a light for this dilemma: using 3D printing technology to build a "smart scaffold" and combined with the neural progenitor cells cultivated by stem cells, it successfully set up a neural pathway in the body of rats with completely broken spinal cord, so that they can restore their walking ability after 12 weeks.
Spinal cord injury: The century-old dilemma of "incurable injuries" in the medical community
The spinal cord is the "information highway" connecting the brain and the body. Once it is completely broken due to a car accident, fall, or other accidents, the nerve signals will be completely interrupted, resulting in paralysis. What’s even more difficult is that central nervous cells almost lose their natural regeneration ability. Traditional treatment methods (such as rehabilitation training, drug intervention) can only relieve symptoms and cannot repair the broken neural circuit.
In the past, the treatment methods of direct injection of stem cells often resulted in disorderly proliferation of cells and made it difficult to form functional neural connections due to the lack of effective guidance for cell growth. This core problem has long restricted the progress of spinal cord injury treatment, until the intersection of 3D printing technology and stem cell biology provided a new path for breaking the deadlock.
3D printing + stem cells: "Smart Scaffold" builds a high-speed road for nerve regeneration”
In response to this challenge, the research team of the Department of Mechanical Engineering of the University of Minnesota deeply integrates the "precision control" of engineering with the "regenerative potential" of biology to create the revolutionary tool of "organoid scaffolding".
The research team first 3D printed the microchannel scaffold using biocompatible materials - these microchannels with a diameter of only 200 microns (about the thickness of a hair) to simulate the microenvironment of normal spinal cord tissue, just like laying a "highway with guardrail" for nerve fibers to ensure that they grow in the target direction. Subsequently, the team injected the "spinal cord nerve progenitor cells" differentiated from human adult stem cells into the scaffold. These "nerve seeds" proliferate and differentiate under the guidance of the scaffold, and after 40 days, a highly ordered neural network - the "mini spinal cord" organoid was "grown" in vitro.
The study pointed out that this "in vitro prefabrication + in vivo transplantation" model effectively avoids the disorder of traditional cell transplantation through physical guidance of the scaffold structure, and provides key technical support for the precise reconstruction of neural circuits.
Rat experiment succeeded: After 12 weeks of paralysis, they stood up again
To verify the effectiveness of the technology, the team selected rats with complete spinal cord fracture (the most severe injury model) for experiments. After transplanting the "mini spinal cord" stent to the injured area, the miracle gradually appeared:
Motor function recovery: 12 weeks after surgery, the BBB motor function score (a professional scale for estimating hindlimb motor ability) in the transplanted rats reached 8.4 points, while the scores of the untreated group and the control group with only empty stent implantation were only 2.25 and 3.6 points. These once completely paralyzed rats can not only support their weight, but also coordinate their limbs to walk.
Neural pathway reconstruction: Electrophysiological tests show that the electrical signals emitted by the brain of rats in the treatment group can be transmitted to the lower limb muscles through new neural circuits, confirming that the "information highway" has been successfully penetrated.
Cell fusion verification: Microscopy observed that human-derived nerve cells not only survive, but also actively extend synapses, "shake hands" with rats' spinal cord nerve endings, forming a stable new connection.
The researchers said this result marks a key step in the field of spinal cord injury treatment. At present, the team is advancing technology optimization: developing degradable scaffolds (avoiding foreign body residue), exploring more complex neural cell combinations (reconstructing sensory functions), and accelerating clinical transformation through multidisciplinary collaboration.
Although clinical applications from rats to humans still need to overcome challenges such as large-scale production and safety assessment, this study undoubtedly illuminates the light of hope for 300,000 spinal cord injury patients around the world - the once "irreversible" paralysis is being re-written by the power of science and technology.
Previous article
Latest developments
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
On the morning of May 17, 2025, an immersive exploration into life sciences and cryomedicine concluded successfully at Jinan Yinfeng Biological Science Park. Hosted by the Shandong Yinfeng Life Science Research Institute, this event offered members a firsthand look into the research base through activities such as ultra-low temperature cryotherapy experiences, brainwave signal acquisition system trials, and expert panel discussions. Participants witnessed the infinite possibilities that cryogenic technology and life sciences hold for humanity.
The international academic platform ScholarGPS recently announced its global lists of Highly Ranked Scholars - Lifetime and Highly Ranked Scholars - Prior 5 Years, recognizing the top 0.05% of scholars across various disciplines. Among the selected Chinese scholars are national-level talents, leading figures in specialized fields, and seasoned academics dedicated to long-term research.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
